Our Team

Alex Advani has spent his consulting career applying his deep analytical experience and skills to biopharmaceutical strategy. His work includes launch strategy, site of care analysis, account profiling, opportunity assessments, and portfolio development strategy. He has deep expertise in multiple therapeutic areas such as hematology/oncology, genetic and rare disease, and infectious disease. Alex received Ph.D. and Master’s degrees in Genetics, Genomics, and Systems Biology from the University of Chicago and a B.A. in Biology from Duke University.

Alonzo is the current Manager of HR and Operations for LifeSci Partners. He brings a wealth of administrative, logistical and leadership expertise to the firm, after having over 15 years of support experience with both internal and external clients at Clear Channel/iHeart Media, Angelo, Gordon & Co., and Citigroup. Known as the “Concierge”, Alonzo is responsible for daily office management operations, assisting in Diversity and Inclusion initiatives, onboarding both new clients and employees, and basically just getting “IT” done. He is a native of Nashville, TN and now resides in NYC as guardian to his dog and cat.

As a consultant, Amanda has focused on the therapeutic areas of oncology and rare neurological diseases. She has experience in the evolution of medical devices and development of specialty pharmacy drug programs. Amanda’s extensive analytical experience has been applied to secondary and primary research. Her previous work includes competitive assessments, development of treatment landscapes, as well as pipeline and clinical development analyses. Prior to consulting, Amanda worked as a postdoc at the University of Chicago where she developed a CRISPR pipeline for human cell culture systems. Her PhD research in cell and structural biology was performed at EMBL in Heidelberg, Germany. Amanda has earned a BS/MS in Chemistry at Stevens Institute of Technology in Hoboken NJ.

Anthony is a Consultant at LifeSci Consulting. Prior to joining LifeSci, he completed a Post-Doctoral Fellowship at the Janssen Pharmaceutical Companies of Johnson & Johnson, where he focused on the development of bispecific antibodies for T-cell redirection in oncology. Anthony received a Ph.D. in Pharmacology and Physiology and completed pre-clinical medical school at Drexel University College of Medicine. He received a B.S. with Honors in Biochemistry at SUNY Geneseo. His doctoral research was in translational oncology, with a focus on developing novel therapeutics for metastatic prostate cancer.
This message contains confidential and proprietary information and is intended only for the individual named. If you are not the named addressee you should not disseminate, distribute or copy this e-mail. Please notify the sender immediately by e-mail if you have received this email by mistake and delete this email from your system. Any comments or statements made herein do not necessarily reflect the views of LifeSci Advisors, LLC, its affiliates, subsidiaries or agents. Before opening any attachments please check them for viruses and defects.

Blake joined LifeSci in March 2022 with over 8 years of academic and industry research experience spanning multiple disciplines including neuroscience (aging, Alzheimer’s Disease, Parkinson’s Disease, and other movement disorders), cardiovascular disease, and genetics. He specialized in the use of imaging techniques (MRI, fMRI, PET) to study the mechanisms underlying degenerative age-related processes in the body. Prior to joining LifeSci, Blake received his B.S. degree in Biomedical Engineering from Rensselaer Polytechnic Institute (RPI) in 2016. He next matriculated in the Neuroscience Graduate Program (NGP) in the Wake Forest School of Medicine and earned his Ph.D. in Neuroscience in 2021. He then completed a postdoctoral research fellowship in the Vanderbilt Memory and Alzheimer’s center.

Chris has spent his career in biopharmaceutical strategy consulting. His work includes commercial due diligence, asset valuation, commercial launch strategy, and portfolio strategy across numerous therapeutic areas. Prior to LifeSci, Chris was a Consultant at Trinity, a life science strategy consulting firm. He received a B.A. in Economics from Middlebury College.

Cristiano has more than 25 years of leadership experience in corporate development, strategy and sales and marketing with experience accross the spectrum of life science companies. Cristiano was previously VP, Head of Corporate Licensing at Grünenthal Pharmaceuticals where he executed some of their major deals. Prior to Grünenthal, Cristiano held various business development, sales and marketing, strategy roles with increasing responsibility at Menarini Pharmaceuticals. Cristiano has supported 18 sell and buy-side transactions totaling over $2B in deal value. Cristiano graduated from the University of Genova Medical School.

Dan joined LifeSci Consulting as an Analyst in June 2022. He graduated from the University of Illinois at Urbana-Champaign where he earned his B.S. with a dual degree in Molecular & Cellular Biology and Economics. Previously, he worked for ABclonal Technology, where he specialized in business development and sales of research-grade antibodies, proteins, and molecular enzyme reagents. He has experience reviewing scientific publications and communicating with researchers and physicians across several therapeutic areas. Additionally, he has experience in healthcare-focused venture capital where he assisted in business strategy and capital raising, as well as gained exposure to multiple market opportunity and regulatory strategy assessments.

Gabby is an Analyst at LifeSci Consulting. Gabby earned her B.S. in Biology at Pepperdine University. Here, she participated in clinical research in regenerative and emergency medicine. Gabby has studied the efficacy of stem cell and PRP treatments on shoulder pain, wrist pain, and lower back pain. Additionally, at Children’s National Medical Center in Washington D.C., Gabby studied the impact of cognitive rest on prolonged concussion symptoms. She has experience in designing clinical research protocols, gathering and analyzing data, and writing scientific publications for peer review. In addition to her clinical research experience, she has experience in biological and chemical research having performed studies extracting and sequencing DNA as well as performing mass spectrometry to analyze chemical samples. Gabby also has experience in business strategy in the skincare industry, performing competitor analyses, pricing strategies, and sales forecasting. She is passionate about merging her interests in science and business strategy.

Houleye focusses on developing evidence-based strategy that supports optimal product value demonstration for commercial success. She brings over her deep consulting expertise in launch strategy, portfolio optimization, and opportunity assessment. Her work spans across US and EU markets, covering multiple therapeutic areas including oncology and rare diseases. Houleye holds a PharmD from Paris Saclay University and a Master's degree in Market Access and HEOR from Paris Descartes University.

Isaac joined LifeSci in June 2021. His work includes competitive landscape assessments, commercial due diligence, and portfolio strategy across several therapeutic areas and modalities. He holds a B.A. in Economics from Cornell University, where he also completed the pre-medicine track. He proceeded to gain an M.S. in Biotechnology from the University of Pennsylvania, with an academic focus on cancer biology and immunology. Prior to joining LifeSci, Isaac worked at the Center for Cellular Immunotherapies (CCI) at the University of Pennsylvania where he conducted lab research on novel CAR-T therapies. He was also a member of Wharton’s Penn Biotech Group (PBG), which consults with clients in the life sciences space.

Isabelle joined LifeSci Consulting as an Analyst in August 2022. She earned her B.A. in Neuroscience from the University of Pennsylvania. She previously worked as a research assistant in Emory University’s Lab of Biomedical Pharmacology, focusing on HIV and Hepatitis B and C research. She was an intern at the San Diego-based venture Human Longevity, where she studied genetics in the context of precision healthcare. There, she worked to contribute to their goal of building the world’s most comprehensive database on human genotypes and phenotypes, which, when subjected to machine learning, are a means to develop innovative solutions to fight diseases associated with aging. Additionally, Isabelle has experience working as an investment analyst at 25Madison and Arcadian Capital where she researched and proposed various investment opportunities, led investor outreach initiatives, and produced investor-facing reports. Isabelle is excited about opportunities in the intersection of business and science where she can continue to leverage her passions and skills.

Jackie joined the team as an Analyst in September 2020, and has focused on developing expertise in market landscapes and opportunity assessments across various therapeutic areas. Prior to joining LifeSci, Jackie worked in patient care coordination and research at a healthcare start up and interned at Acer Inc. Jackie received her B.S. in Biology from the University of California, Los Angeles. During her time at UCLA, she participated in ecology and evolutionary biology research as part of the Yeh Lab and was actively involved in campus-wide entrepreneurship initiatives.

Jason joined LifeSci Consulting as an Analyst in July 2022. Before LifeSci, he interned for a biotechnology startup in the Bay Area, where he identified and utilized bioinformatic data to construct cancer proteomic databases. Jason earned a B.S. in Molecular and Medical Microbiology as well as a B.A. in Economics from the University of California, Davis.

Jason has over 12 years of experience in the life sciences industry supporting transactions and executing strategy consulting engagements across numerous therapeutic areas. Jason has supported sell-side and buy-side transactions totaling over $3.5B in deal value and has executed >150 strategy consulting engagements. Jason was previously a co-founder of the Partnering & Analytics division at LifeSci Partners prior to the formation of LifeSci Consulting, which was the result of the merger with Corsica Life Sciences. Jason received an M.B.A. from the McColl School of Business at Queens University of Charlotte and a B.S. in Physics and Math from Siena College.

Jeff has over 9 years' experience in consulting encompassing over 100 consulting engagements spannign therapeutic areas and project types. Areas of particularly deep expertise include neurobiology, rare disease, specialty pharmaceuticals, competitive strategy, and product launch. Jeff is excited to bring the expanded capabilities of LifeSci consulting to bear for existing as well as new clients.

Prior to the merger which created LifeSci Consulting, Jeff was a founding team member of Corsica Life Sciences and a consultant with Campbell Alliance/Syneos Health.

Jeff received a Ph.D. in Human Genetics from the University of Chicago and a B.S. in Genetics from Iowa State University.

Joe is a Manager at LifeSci Consulting, where his work spans competitive intelligence analyses, commercial opportunity assessments, asset valuation analyses, and strategic partnering advisory across numerous therapeutic areas. Prior to joining LifeSci, he was a Strategic Partnerships Lead at nference, a Biomedical AI firm, where he built strategic partnerships with pharma companies and leveraged analytical tools for drug discovery engagements. Prior to nference, he was a Venture Fellow at Spartan Innovations, where he developed commercialization strategies for university technologies, including a gene therapy platform for CNS therapeutics. He holds a PhD in Biomedical Engineering and a BS in Neuroscience through an accelerated BS/PhD program at Michigan State University. His doctoral research developed genetic engineering and electrophysiological techniques to improve the use of microelectrode arrays implanted in the brain. His PhD produced 10+ peer-reviewed scientific publications.

Leah has spent the last 5+ years in life sciences and healthcare consulting leveraging her deep analytical and pharmacological experience. Having joined the LifeSci team in 2021 from Putnam Associates, she continues to manage the strategic assessment and execution of scientific, clinical, and commercial goals in areas including: oncology/hematology, rare diseases, vaccines and cell & gene therapy. Prior to joining Putnam Associates, Leah worked and mentored graduate teams in pro bono consulting enagements for Boston-based biotechnology start-up firms. She received her Ph.D. from Boston University School of Medicine in Pharmacology and a B.A. in Chemistry from Mount Holyoke College.

Matt is Vice President of Business Development at LifeSci Consulting where he leads all new business efforts globally. Matt joins LifeSci Consulting after spending 15 years working closely with life sciences companies in both the private and public domain, ranging from emerging biotech to major pharma. At his previous firm, he was instrumental in focusing growth efforts in the life sciences vertical.

Matt strongly values his client relationships and seeks optimal ways for LifeSci Consulting to support their corporate initiatives.

Matt holds a Bachelor of Science in Finance from Bentley University.

Matthew brings over 20 years' experience to his work supporting clients across the life sciences industry, from large multinational to preclinical startup. Matthew’s work focuses predominantly on new product planning, go-to-market strategy, portfolio strategy and optimization, and organizational design.

Prior to LifeSci Consulting, Matthew co-founded Corsica Life Sciences and helped established it as leading boutique commercial strategy consulting firm. Matthew has a BSc in Genetics from Liverpool University, UK.

Matthew has spent the past 3+ years working in life sciences and healthcare consulting. Now a Senior Consultant, he applies his background and experience in launch strategy, opportunity assessment, and new product planning. He has worked across a variety of therapeutic areas where he has conducted primary research with physicians, payers, and patients. Matthew received his B.S. in Chemistry from the University of Southern California. During his time at USC, he was an undergraduate research assistant in the Jung Lab where he worked on the design and synthesis of novel catalysts to facilitate the discovery of deuterium labelled pharmaceutical compounds.

Michael has more than 15 years of experience providing strategic advisory services life sciences companies from across the globe. Michael has supported transactions totaling over $3.3 billion and executed 150+ strategic consulting mandates spanning various therapeutic areas to include Oncology, CNS, Immunology, Inflammation, Dermatology, and Ophthalmology. Michael previously co-founded LifeSci Partnering and Analytics which merged with Corsica Life Sciencs to form LifeSci Consulting. Michael received a B.A. in Economics and English from the University of North Carolina at Chapel Hill.

Michael has more than 25 years of strategy and finance experience, including over 20 years of experience in product strategy, product launch, competitive strategy and portfolio strategy. He is a strategic advisor to life sciences companies, bringing experience across most therapeutic areas, as well as complex specialty products and cell and gene therapy. Michael was previously a partner with several strategy consulting firms, including Campbell Alliance (now Syneos Health), where he led commercial strategy for the Eastern U.S. and led launch globally. He has successfully delivered 400+ strategy engagements with life sciences clients throughout his career. He received a M.B.A. from Ross School of Business at University of Michigan and a B.S. in Engineering from Cornell University.

Mike is a Partner with LifeSci Consulting and a leader in the Chicago/Midwest office. He has 15+ years of experience supporting the development of foundational commercialization strategy for life sciences clients of all sizes, stages of development, and therapeutic focus. Previously, Mike was a Partner with Corsica Life Sciences and a Director with Syneos Health Mike has a PhD from University of Chicago in Neurobiology and BS from Brandeis University in Neuroscience

Mike joined the LifeSci Consulting team in November 2019. He has experience executing various strategy consulting engagements across numerous therapeutic areas. His work includes commercial opportunity assessments, asset valuations, portfolio strategy assessments, and transaction comparables analyses. Prior to joining LifeSci, Mike graduated from the College of the Holy Cross with a B.A. in Economics.

Robert has more than 15 years of experience across early R&D and all aspects of commercialization strategy. Over the past decade plus, Robert has partnered with clients from top-10 Biopharma to pre-Series A start-ups to develop actionable strategies across both Commercial and Market Access issues. Robert co-founded and helped grow Corsica Life Sciences Consulting into a premier boutique Commercial Strategy firm, and is excited to bring the same passion and expertise to LifeSci Consulting. Prior to founding Corsica, Robert helped drive the diversification of Campbell Alliance's Southwest Region’s client base into the growing Orange County / San Diego markets. Robert received an MBA from Hough Graduate School of Business at the University of Florida; a PhD in Computational Biochemistry from University of Florida; and a BA in Biochemistry from the University of San Diego.

Trey has spent his career supporting informed strategic decision-making for companies operating in the life sciences field. He has experience driving over 150 consulting engagements to enhance the corporate and business development efforts of clients across therapeutic areas, including the facilitation of strategic transactions totaling over $750 M in total deal value. Prior to joining LifeSci, Trey was a project lead at ClearView Healthcare Partners managing strategy consulting mandates for big pharma and innovative biotech organizations. He received a B.S. in Chemical Engineering from Yale University and conducted biomedical and engineering research within the Van Tassel lab group.

Tyler has been a member of the LifeSci Consulting team since August 2021, where he has focused on a variety of projects including competitive intelligence and commecial opportunity assessments. Prior to joining LifeSci, Tyler has worked in several different laboratories especially investigating tumor margin optimization in breast cancer lumpectomies. He was also a trained emergency medical technician (EMT) and COVID-19 contact tracer. He graduated from Bucknell University with a B.A. in Biology. During his time at Bucknell he served as a two-year captain of the Men’s Varsity Soccer Team, held positions on several campus leadership committees, and was a strong contributor to the Lewisburg community.

Vanessa joined the LifeSci Consulting team in April 2021. Her work includes asset valuation, transaction comp analyses, competitive landscape, and commercial opportunity assessments across several therapeutic areas. Prior to joining LifeSci, Vanessa worked at the Yale Center for Clinical Investigation supporting clinical research related to COVID-19. She graduated from Yale University with a B.A. in History of Science, Medicine, and Public Health and completed the pre-medicine track. During her time at Yale, she conducted research in the Chun Lab at the Yale Cardiovascular Research Center, served as captain of the Women’s Varsity Lacrosse Team, and volunteered for a non-profit organization called Camp Kesem.

Xinxin is a Senior Consultant at LifeSci Consulting. She worked as a Consultant at Corsica Life Sciences starting September 2020 and has focused mainly on market landscape and opportunity assessment. She has significant experience in conducting primary and secondary market research in various therapeutic areas including oncology and rare diseases. Prior to Corsica, Xinxin graduated from University of California San Diego with her PhD in Biomedical Sciences, with research projects in genetics and genomics. Prior to UCSD, she started her graduate school at University of Chicago before her lab moved from Chicago to San Diego. Before graduate school, Xinxin graduated Smith College with double majors in Biological Sciences and Psychology.